High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.
about
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleedingProton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleedingHigh-dose vs low-dose proton pump inhibitors for upper gastrointestinal bleeding: a meta-analysisDiagnosis and therapy of non-variceal upper gastrointestinal bleedingPantoprazole for the treatment of peptic ulcer bleeding and prevention of rebleedingProton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics.Barriers to the implementation of practice guidelines in managing patients with nonvariceal upper gastrointestinal bleeding: A qualitative approach.Doppler endoscopic probe as a guide to risk stratification and definitive hemostasis of peptic ulcer bleeding.Partially covered self-expandable metal stents versus polyethylene stents for malignant biliary obstruction: a cost-effectiveness analysisReview article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.Review article: acid-related disease--what are the unmet clinical needs?The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis.A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers.Intravenous esomeprazole: a pharmacoeconomic profile of its use in the prevention of recurrent peptic ulcer bleeding.Timing or Dosing of Intravenous Proton Pump Inhibitors in Acute Upper Gastrointestinal Bleeding Has Low Impact on Costs.Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial.Efficacy Comparison of Divided and Infusion Intravenous Pantoprazole Methods after Endoscopic Therapy in Patients with Acute Gastrointestinal Bleeding.Clinical practice and evidence in endoscopic treatment of bleeding peptic gastroduodenal ulcer.Management of non-variceal upper gastrointestinal bleeding.Cost-effectiveness of high-dose intravenous esomeprazole in patients with peptic ulcer bleeding in the USA and Europe.Greater immediate gastric acid suppression with lansoprazole 30 mg administered as a 2-minute intravenous bolus injection versus a 30-minute infusion.
P2860
Q24234193-FDB7FF15-7D40-488D-8A80-131DE6AA5D1BQ24244325-88F48E3A-8F88-4AC4-9116-71A764994233Q24605656-6D41575E-66A0-4EDF-AC21-FD9E8EC7C476Q26777626-DDA3468A-6E03-4141-BD4D-A43D6C186A50Q27025841-4B45A275-AED3-4ABA-A941-B235E3C0C65BQ33224563-9A78FD75-87BB-4127-81D7-332C0C1F4F85Q33916726-6AD30A69-470C-4947-82B4-E6CA21943081Q35759442-9CE05A43-3CEA-4252-B543-31445C2A93B3Q36176482-C58D3192-D859-4F4B-B030-E1C108BF7FE0Q36319521-1DF9B6F8-C648-4727-8E1D-A0F8EF3577FCQ36478873-CFB4617B-2CB6-4C79-AE73-0D02981F5B51Q37140226-6C55F824-E8FC-4DA0-97B7-B18D67A2C242Q37823319-B4DAFAAB-5F5E-418B-BE84-7A51BEA84BE3Q37875052-50D50D0C-C0A9-429A-BDD6-7A18BFFD6B09Q39799633-15DC31F6-5864-4D06-98B8-F0A19CFF7907Q41690757-11B9A3EE-4782-493C-81B4-43219365E555Q42010277-A12DBCC7-AA71-4648-BC29-5D41FD78C62BQ42166983-2592FED3-335E-46DA-AA71-2AD5D5B831E5Q42321675-4CB43649-9233-4567-8CEB-35F08CA21CEDQ42935114-89F23013-6A3A-4C49-A56E-758B062CEE2EQ46738444-D5EDE622-DBA0-4BF0-BA08-C486C51FDD34
P2860
High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
High-dose intravenous proton p ...... a cost-effectiveness analysis.
@en
High-dose intravenous proton p ...... a cost-effectiveness analysis.
@nl
type
label
High-dose intravenous proton p ...... a cost-effectiveness analysis.
@en
High-dose intravenous proton p ...... a cost-effectiveness analysis.
@nl
prefLabel
High-dose intravenous proton p ...... a cost-effectiveness analysis.
@en
High-dose intravenous proton p ...... a cost-effectiveness analysis.
@nl
P2093
P2860
P1476
High-dose intravenous proton p ...... a cost-effectiveness analysis.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2004.01808.X
P407
P577
2004-03-01T00:00:00Z